Sangamo Biosciences (SGMO) Stock Research

SGMO

· SGMO

Over a week ago

Nasdaq says to delist Nuvve Holding, Maxeon Solar, Sangamo

Sep 17, 9:34 AM

Five new option listings and two option delistings on June 24th

Jun 24, 8:30 AM

Sangamo files for restructuring, plans asset sales to Lilly, Astellas

Jun 23, 9:12 AM

Sangamo price target lowered by $5 at H.C. Wainwright, here's why

SGMO

May 26, 11:12 AM

Sangamo sees FY26 operating expenses $8M

SGMO

Mar 30, 4:08 PM

Sangamo reports Q4 EPS (11c), consensus (5c)

SGMO

Mar 30, 4:07 PM

Sangamo options imply 27.2% move in share price post-earnings

SGMO

Mar 30, 3:11 PM

Sangamo advances rolling submission of BLA to FDA for ST-920

SGMO

Mar 9, 8:07 AM

Sangamo names Nikunj Jain as interim CFO, principal financial officer

SGMO

Feb 3, 9:15 AM

Sangamo says principal financial officer Prathyusha Duraibabu terminated

SGMO

Feb 3, 9:15 AM

Sangamo says preliminary cash, equivalents at December 31 $20.9M

SGMO

Feb 3, 9:14 AM

Sangamo prices 35.2M shares at 47.19c in underwritten offering

SGMO

Feb 3, 9:12 AM

Sangamo initiates rolling submission of BLA to U.S. FDA for ST-920

SGMO

Dec 18, 8:11 AM

Sangamo receives U.S. FDA Fast Track Designation to ST-503

SGMO

Dec 2, 8:21 AM

What You Missed On Wall Street On Friday

+27

Nov 21, 4:14 PM

Midday Fly By: Bitcoin slides, Lilly hits $1T market cap

+28

Nov 21, 12:02 PM

Sangamo announces FDA acceptance of BLA rolling submission request for ST-920

SGMO

Nov 21, 8:08 AM

Sangamo just downgraded at Barclays, here's why

SGMO

Nov 7, 4:38 AM

Sangamo sees FY25 operating expenses $135M-$155M

SGMO

Nov 6, 8:12 AM

Sangamo sees cash runway into 1Q26

SGMO

Nov 6, 8:11 AM

Sangamo reports Q3 EPS (11c), consensus (10c)

SGMO

Nov 6, 8:11 AM

No more stories

Charts

Over a week ago

Nasdaq says to delist Nuvve Holding, Maxeon Solar, Sangamo

Sep 17, 9:34 AM

Five new option listings and two option delistings on June 24th

Jun 24, 8:30 AM

Sangamo files for restructuring, plans asset sales to Lilly, Astellas

Jun 23, 9:12 AM

Sangamo price target lowered by $5 at H.C. Wainwright, here's why

SGMO

May 26, 11:12 AM

Sangamo sees FY26 operating expenses $8M

SGMO

Mar 30, 4:08 PM

Sangamo reports Q4 EPS (11c), consensus (5c)

SGMO

Mar 30, 4:07 PM

Sangamo options imply 27.2% move in share price post-earnings

SGMO

Mar 30, 3:11 PM

Sangamo advances rolling submission of BLA to FDA for ST-920

SGMO

Mar 9, 8:07 AM

Sangamo names Nikunj Jain as interim CFO, principal financial officer

SGMO

Feb 3, 9:15 AM

Sangamo says principal financial officer Prathyusha Duraibabu terminated

SGMO

Feb 3, 9:15 AM

Sangamo says preliminary cash, equivalents at December 31 $20.9M

SGMO

Feb 3, 9:14 AM

Sangamo prices 35.2M shares at 47.19c in underwritten offering

SGMO

Feb 3, 9:12 AM

Sangamo initiates rolling submission of BLA to U.S. FDA for ST-920

SGMO

Dec 18, 8:11 AM

Sangamo receives U.S. FDA Fast Track Designation to ST-503

SGMO

Dec 2, 8:21 AM

What You Missed On Wall Street On Friday

+27

Nov 21, 4:14 PM

Midday Fly By: Bitcoin slides, Lilly hits $1T market cap

+28

Nov 21, 12:02 PM

Sangamo announces FDA acceptance of BLA rolling submission request for ST-920

SGMO

Nov 21, 8:08 AM

Sangamo just downgraded at Barclays, here's why

SGMO

Nov 7, 4:38 AM

Sangamo sees FY25 operating expenses $135M-$155M

SGMO

Nov 6, 8:12 AM

Sangamo sees cash runway into 1Q26

SGMO

Nov 6, 8:11 AM

Sangamo reports Q3 EPS (11c), consensus (10c)

SGMO

Nov 6, 8:11 AM

No more stories

Company News

Charts

SGMO

· SGMO

Company News

Charts

SGMO

· SGMO